[Drug activation of GABAergic transmission in the central nervous system: benzodiazepines and GABAergic agonists].
Moura
D
D
Soares-da-Silva
P
P
D000818:Animals; D001569:Benzodiazepines / Q000494:pharmacology*; D001570:Benzodiazepinones / Q000494:pharmacology; D001921:Brain / Q000502:physiology*; D002243:Carbolines / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D006152:Cyclic GMP / Q000378:metabolism; D003975:Diazepam / Q000494:pharmacology; D005442:Flumazenil; D006801:Humans; D011963:Receptors, GABA-A / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D014635:Valproic Acid / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*
D001570:Benzodiazepinones; D002243:Carbolines; D011963:Receptors, GABA-A; D001569:Benzodiazepines; C017985:progabide; D005442:Flumazenil; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; C024915:beta-carboline-3-carboxylic acid ethyl ester; C028585:propyl beta-carboline-3-carboxylate; D006152:Cyclic GMP; C036150:beta-carboline-3-carboxylic acid methyl ester; D003975:Diazepam
Activação farmacológica da transmissão GABAérgica no sistema nervoso central: benzodiazepinas e agonistas GABAérgicos.